https://forbion.com/news-insights/news/bluebird-bio-secures-60-million-in-oversubscribed-financing/
bluebird bio Secures $60 Million in Oversubscribed Financing | Forbion
bluebird biosecuresmillionoversubscribedfinancing
https://aldconnect.org/news/bluebird-bio-receives-fda-accelerated-approval-for-skysona-gene-therapy/
bluebird bio Receives FDA Accelerated Approval for SKYSONA® Gene Therapy for Early, Active Cerebral...
Oct 13, 2024 - bluebird bio receives FDA accelerated approval for SKYSONA gene therapy, the first FDA approved treatment for early, active cerebral ALD.
fda accelerated approvalbluebird biogene therapyreceivesearly
https://business.times-online.com/times-online/article/bizwire-2022-6-7-bluebird-bio-announces-posting-of-briefing-documents-for-upcoming-fda-advisory-committee-meeting
User | times-online.com - bluebird bio Announces Posting of Briefing Documents for Upcoming FDA...
bluebird bio Announces Posting of Briefing Documents for Upcoming FDA Advisory Committee Meeting
user timesbluebird bioonlineannouncesposting
https://news.balentic.com/news/article/AZbD_XMSs1keK2bmI5kcEQ/carlyle-and-sk-capital-partners-announce-extension-of-bluebird-bio-tender-offer-to-may-2-2025
Balentic news - Carlyle and SK Capital Partners Announce Extension of bluebird bio Tender Offer to...
Apr 16, 2025 - Carlyle, SK Capital, and Beacon Parent Holdings have extended their tender offer to acquire all outstanding shares of bluebird bio (NASDAQ: BLUE) until May 2,...
bluebird biotender offernewscarlylecapital
https://www.pharmaceuticalprocessingworld.com/milliporesigma-signs-commercial-supply-agreement-with-bluebird-bio/
MilliporeSigma Signs Commercial Supply Agreement With Bluebird Bio - Pharmaceutical Processing World
Oct 11, 2019 - MilliporeSigma today announced that it has signed a commercial supply agreement to manufacture viral vectors for bluebird bio, Inc., of Cambridge, MA, for its...
supply agreementbluebird biopharmaceutical processingmilliporesigmasigns